The Effect of Supportive Educative Program in COVID-19

Comparing of the Effect of Supportive Educative Program with Routine educative program on Stress, Anxiety, Depression and Satisfaction of Patients With COVID-19 Admitted to COVID units

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20140625018231N1

Enrollment

Registered

2021-11-05

Start date

2021-10-22

Completion date

Unknown

Last updated

2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19. COVID-19, virus identified

Interventions

Intervention 1: Intervention group: expressing empathy with patient and focusing on his concerns at the beginning of the patient's awareness of the diagnosis of COVID-19, Provide the patient with a co

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Positive COVID-19 PCR test and definit diagnosis of COVID-19 COVID-19 Patient with P/F ratio <200 Definite need to be hospitalized in COVID-19 ward Full awareness and awareness to time and place

Exclusion criteria

Exclusion criteria: Having a history of mental disorders Employment in the treatment team Having a previous history of COVID-19 Having a history of using psychotropic drugs and narcotics

Design outcomes

Primary

Measure	Time frame
Level of depression. Timepoint: immediately after hospitalization, at the end of the first day of hospitalization and 5 days after hospitalization in both control and intervention groups. Method of measurement: Depression, Anxiety and Stress Questionnaire (DASS).;Level of Anxity. Timepoint: immediately after hospitalization, at the end of the first day of hospitalization and 5 days after hospitalization in both control and intervention groups. Method of measurement: Depression, Anxiety and Stress Questionnaire (DASS).;Level of Stress. Timepoint: immediately after hospitalization, at the end of the first day of hospitalization and 5 days after hospitalization in both control and intervention groups. Method of measurement: Depression, Anxiety and Stress Questionnaire (DASS).;Patient satisfaction with the quality of care. Timepoint: For both intervention and control groups 5 days after hospitalization. Method of measurement: Patient Satisfaction Questionnaire (PSI) to measure patient satisfaction with the quality of care.	—

Measure

Time frame

Level of depression. Timepoint: immediately after hospitalization, at the end of the first day of hospitalization and 5 days after hospitalization in both control and intervention groups. Method of measurement: Depression, Anxiety and Stress Questionnaire (DASS).;Level of Anxity. Timepoint: immediately after hospitalization, at the end of the first day of hospitalization and 5 days after hospitalization in both control and intervention groups. Method of measurement: Depression, Anxiety and Stress Questionnaire (DASS).;Level of Stress. Timepoint: immediately after hospitalization, at the end of the first day of hospitalization and 5 days after hospitalization in both control and intervention groups. Method of measurement: Depression, Anxiety and Stress Questionnaire (DASS).;Patient satisfaction with the quality of care. Timepoint: For both intervention and control groups 5 days after hospitalization. Method of measurement: Patient Satisfaction Questionnaire (PSI) to measure patient satisfaction with the quality of care.

—

Countries

Iraq

Contacts

Public ContactFateme Hajiabadi

Mashhad University of Medical Sciences

hajiabadif@mums.ac.ir+98 51 3859 1511

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026